Delivery Order SPE2DB22D2007-SPE2DB25FJ3NK
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Jardiance 25 mg tablets (90-count) with a ceiling value of $4,120.39. This is a firm fixed-price delivery order with no set-aside designation, issued under a competitive procurement process. The order is scheduled for completion by July 25, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Jardiance is a diabetes...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Jardiance 25 mg tablets in a quantity of 90-count packages. This competitive award, valued at $6,795.94, carries a firm fixed price structure with an ultimate completion date of August 8, 2025. The contract represents a child order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Jardiance 25 mg tablets (90-count units) with a ceiling value of $14,137.08. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The contract is scheduled for ultimate completion on July 28, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Jardiance is a medication...
- The Defense Logistics Agency awarded a delivery order valued at $6,496.48 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count packages) on August 1, 2025, with an ultimate completion date of August 4, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Jardiance is a diabetes medication commonly used within military and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Jardiance 10 mg tablets in a 90-count package. This is a firm fixed-price delivery order with a ceiling value of $6,102.58 and an ultimate completion date of July 21, 2025. The contract utilizes no set-aside designation and represents a competitively awarded procurement. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order valued at $11,632.89 to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Jardiance 10 mg tablets (90-count packages). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of July 23, 2025, with performance at the vendor's facility in Conshohocken, Pennsylvania. Jardiance is a diabetes medication commonly prescribed for type 2 diabetes management, reflecting the critical pharmaceutical supply needs...
- The Defense Logistics Agency awarded a delivery order valued at $21,234.32 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count units) on July 22, 2025, with an ultimate completion date of July 23, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Jardiance is a prescription medication used in diabetes management,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Jardiance 25 mg tablets (90-count units) with a ceiling value of $1,530.68. This competitively awarded, firm fixed-price delivery order, with an ultimate completion date of July 25, 2025, represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the federal government. The contract carries no set-aside designation, reflecting the...
- The Defense Logistics Agency awarded a delivery order valued at $7,255.18 to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Jardiance 10 mg tablets (90-count packages). This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of July 31, 2025. The contract will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Jardiance is a prescription medication commonly used in diabetes management, aligning with...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Jardiance 25 mg tablets (90-count units) with a contract value of $9,749.76. This firm fixed price delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999.99 million through December 2026. The award was competitively procured with no set-aside designation, and the place of...
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB25FJ3NKDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Jardiance 10 mg tablets in a quantity of 90 units. This competitively awarded, firm fixed-price delivery order carries a ceiling value of $18,493.98 and is scheduled for completion by August 4, 2025. The contract involves no set-aside designation and identifies AmerisourceBergen's Conshohocken, Pennsylvania facility as the place of performance. Jardiance is a widely-used antidiabetic medication, reflecting the Defense Logistics Agency's ongoing pharmaceutical supply needs for military and veteran healthcare systems. This delivery order operates as a child contract under AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The parent contract serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs worldwide. AmerisourceBergen's federal pharmaceutical contract portfolio demonstrates the company's established capability to fulfill competitive federal medical procurement requirements across multiple therapeutic domains for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $18.5k | 8/1/25 |